FDA PDUFA review goal date of March 27, 2025 for CARDAMYSTâ„¢ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) Assuming FDA approval, proposed launch in PSVT targeted for ...
Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-year Strong growth in key commercial metrics, including prescriber base, fill rates, and patient enrollments ...
Prerna Arora made a very impressive debut as a producer in the Hindi film industry. She was involved with some very ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...
This week saw the return of iconic department store Debenhams after it was closed down three years ago, following a takeover ...
Q4 2024 Earnings Call Transcript March 12, 2025 Amarin Corporation plc beats earnings expectations. Reported EPS is $-0.03, ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...
including refining the issuance and registration process for sci-tech innovation bonds and advancing the securitization of intellectual property assets, according to the commission. "We are ...
If the film were better, the director could get away with it.
INVINCIBLE-3 Study, and 25 patients have been screenedEight Swiss sites are activated in the INVINCIBLE-4 Study, and several patients have been screenedFinal sarcoma data from our first metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback